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Edited by Gianni CesareniAbstract The Na+-driven Cl=HCO3 exchanger (NCBE)
plays an important role in the regulation of intracellular pH
(pHi). We previously identiﬁed two variants of NCBE from rat
brain of which the variant with a carboxyterminal PSD-95/
Dlg/ZO-1 (PDZ) motif (rb2NCBE) colocalized with the actin
cytoskeleton. Increased rb2NCBE activity by PKA inhibition
and reduction by forskolin and cAMP agonist suggest PKA reg-
ulation of NCBE. Disruption of actin ﬁlaments also decreased
rb2NCBE activity. EBP50 and FLAG-rb2NCBE were recipro-
cally co-immunoprecipitated from rb2NCBE transfected cells.
It is concluded that NCBE activity is inhibited by PKA and de-
pends on the integrity of the actin cytoskeleton within a multi-
protein complex at the plasma membrane.
 2006 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Regulation of intracellular pH (pHi) is an essential homeo-
static function of all cells. Rapid pH transients in the brain
associated with normal physiological function and prominent
pH changes during pathophysiological conditions, such as
ischemia, make understanding the regulation of pHi of great
importance [1]. HCO3 transport has been described in nearly
all cells and is an essential mechanism in the regulation of
pHi [2]. Three types of HCO

3 transporters have been described
in mammalian cells [3]: anion exchangers or Na+-independent
Cl=HCO3 exchangers, Na
þ=HCO3 cotransporters (NBC),
and Na+-dependent Cl=HCO3 exchangers (NCBE or
NDAE) [4,5]. We recently isolated two cDNA variants of
NCBE from rat hippocampus, called rb1NCBE (GenBank
accession no. AF439856) and rb2NCBE (GenBank accession
no. AF439855) [6], the latter containing a PDZ motif at the
carboxy terminus of the deduced amino acid sequence. NCBE
has ten membrane spanning segments based on the automated
server for predicting transmembrane helices and topology of
protein [7]. Sequence analysis of rb2NCBE using ELM data-
base [8] predicted 14 consensus phosphorylation sites for*Corresponding author. Fax: +1 650 725 8052.
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PKA phosphorylation site in the cytoplasmic COOH-terminus
of rb2NCBE. However, whether rb2NCBE activity is regu-
lated by PKA has not yet been studied.
In epithelia, the activity of the sodium hydrogen exchanger 3
(NHE3) is regulated by interaction with several proteins. These
include NHE regulatory factor/ezrin binding protein 50
(NHERF/EBP50), which is a PDZ domain protein, ezrin, an
actin binding protein that also anchors PKA and binds
EBP50, and the state of assembly of the actin cytoskeleton
[9–11]. Compared to the current understanding of mechanisms
of NHE regulation, there are few reports regarding the regula-
tion of HCO3 dependent transporters. Increased levels of
cAMP stimulated Cl=HCO3 exchange and Na
þ=HCO3 sym-
port activity in rat hepatocytes [12] and Na+ dependent and
independent Cl=HCO3 exchange in human biliary epithelial
cells [13]. In contrast, PKA inhibited renal NBC activity in
conjunction with NHERF/EBP50 [14]. PKA also inhibited
electrogenic Naþ=HCO3 cotransport in lymphocytes [15].
These ﬁndings prompted us to investigate the potential role
of PKA and cAMP in regulating rb2NCBE activity. Trans-
porter activity was measured using rb2NCBE expressing 3T3
cells after incubating with PKA activators and inhibitors and
the adenylate cyclase inhibitor, forskolin. We previously noted
higher transport activity and extensive co-localization of the
PDZ-motif containing rb2NCBE with actin ﬁlaments [6], rais-
ing the possibility that the transporter may associate with the
actin cytoskeleton via its PDZ motif and interact with addi-
tional regulatory proteins. The eﬀect of the state of actin poly-
merization on transporter activity was tested by disrupting
actin ﬁlaments with cytochalasin B. Double immunostaining
and co-immunoprecipitation were performed to assess co-
localization and interaction of rb2NCBE and EBP50.2. Materials and methods
2.1. Chemicals
2 0,7 0-Bis(carboxyethyl)-5(6)-carboxyﬂuorescein acetoxymethyl ester
(BCECF-AM) was purchased from Molecular Probes (Eugene, OR,
USA). PKA inhibitor Fragment 14–22, cytochalasin B, phalloidin, for-
skolin, 8-Br-cAMP and protein-A-agarose were purchased from Sigma
Chemicals.
2.2. Plasmids and retroviral vector expression
The FLAG epitope was added in frame at the N-terminus of
rb2NCBE and this tagged construct was stably expressed in 3T3 cells
or primary astrocytes using a retroviral vector [6]. A control vector
containing LacZ was also used [16]. Antibiotic selection with G418
was used to produce cultures in which essentially all the cells expressed
the gene of interest.ation of European Biochemical Societies.
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All procedures were carried out according to a protocol approved by
the Stanford University Animal Care and Use Committee and were in
keeping with the NIH guidelines. Primary cultures of cortical astro-
cytes isolated from P1-2 Swiss Webster mice (Simonsen, Gilroy, CA)
were prepared [17] and transfected with the retroviral vectors as previ-
ously described [6,16]. Mouse ﬁbroblast 3T3 cells were cultured in Dul-
becco’s modiﬁed essential medium, 10% fetal bovine serum, and
antibiotic antimycotic (penicillin 100 U/ml, streptomycin 100 U/ml,
and fungizone 0.25 lg/ml), equilibrated with 5% CO2-95% air at 37 C.
2.4. Measurement of intracellular pH
NIH 3T3 cells expressing the FLAG-rb2NCBE transporter were
plated on coverslips and grown until they reached 60–80% conﬂuence.
Transport activity was assessed by measuring pHi using 2
0,7 0-bis-(2-
carboxyethyl)-5-(6)-carboxyﬂuorescein, acetoxymethyl ester (BCECF-
AM, Molecular Probes) as previously described [6,18]. Cells were
loaded with BCECF-AM for 30 min and monitored for changes in
pHi by ratiometric analysis using a Sutter ﬁlter wheel for dual wave-
length excitation (490 nm/450 nm) monitoring emission at 540 nm
using Axon Imaging Workbench 4.0 (Axon Inc., Foster City, CA).
The pHi calibration was generated using the KCl/nigericin technique
[18]. Coverslips were mounted in a chamber adapter on an inverted Ni-
kon Diaphot microscope. Pre-selected ﬁelds were illuminated by a Xe-
non light source using a Nikon 40·/1.3 NA epiﬂuorescence oil
immersion objective and the emitted ﬂuorescence imaged using a Sen-
siCam CCD 12 bit digital camera (PCO Imaging, Kelheim, Germany).
Cells were subjected to intracellular acidiﬁcation using NH4 prepulse
by exposure to 40 mM NH4Cl in recovery solution for 5 min before
changing to recovery solution without NH4Cl [4–6]. The recovery solu-
tion had the following composition (mM): 140 Na+, 123 Cl, 5 K+,
1Ca2+, 1 Mg2+, 1 PO34 , 5 glucose, 20 HCO

3 and 10 mM HEPES
(pH 7.4) and was equilibrated with 95% O2, 5% CO2. All solutions con-
tained 1 mM 5-(N-ethyl-N-isopropyl)-amiloride (EIPA) to inhibit
NHE activity. All assays were carried out at 30 C.
2.5. Treatment with activators and inhibitors
Transport activity of NCBE assessed as the initial slope of recovery
of pHi was compared under control and experimental conditions. Cells
were acid loaded and then switched to recovery solution to establish
control rates. Cells were incubated with 10 lM cytochalasin B for
10 min to disrupt actin ﬁlaments. Cells were incubated with 10 lM
of the adenylate cyclase activator forskolin, 10 or 50 lM of either
PKA activator 8-Br-cAMP or PKA inhibitor fragments 14–22 for
30 min, prior to measuring the pHi recovery.
2.6. Immunoﬂuorescence microscopy
Primary astrocytes stably expressing the transporter FLAG-
rb2NCBE were grown on coverslips and ﬁxed with 4% paraformalde-
hyde for 20 min and permeabilized by 0.1% Triton X-100 for 5 min.
After blocking for 1 h in PBS containing 5% horse serum, FLAG
tagged rb2NCBE was detected as described previously [6], using mouse
anti-FLAG M2 monoclonal antibody (Sigma, dilution 1:500) and de-
tected with Texas Red anti-mouse IgG conjugate (Vector Laborato-
ries, Inc. dilution 1:100). EBP50 was detected using a rabbit
polyclonal anti-EBP50 antibody (Chemicon, Temecula, CA, dilution
1:500) and visualized with Fluorescein anti-rabbit IgG conjugate (Vec-
tor Laboratories, Inc. dilution 1:100). Ezrin was detected by monoclo-
nal anti-ezrin antibody (Sigma, dilution 1:500) and visualized with
Texas Red anti-mouse IgG conjugate (Vector Laboratories, Inc. dilu-
tion 1:100). Actin ﬁlaments were visualized by Phalloidin-TRITC (Sig-
ma, dilution 1:200).
2.7. Membrane fractionation
Astrocytes or 3T3 cells were collected then sonicated in ice-cold
homogenizing buﬀer (HB, in mM: 250 sucrose, 20 HEPES, pH 7.4 with
HCl, 100 NaCl, 2 sodium EDTA, 1 PMSF, 0.001 leupeptin, and 0.001
pepstatin). The homogenates were then centrifuged at 1000 · g for
15 min to remove cellular debris. The supernatant was then centrifuged
at 100000 · g for 30 min. The resulting microsomal pellet containing
plasma membranes was resuspended in 100 ll of HB containing
0.5% Triton X-100 (Sigma) and centrifuged (30 min at 100000 · g,
4 C). The supernatant which contained the ﬁnal membrane fraction
was used for co-immunoprecipitation.2.8. Co-immunoprecipitation
Protein concentrations were determined by BCA protein assay
(Pierce, Rockford, IL), and 70 lg of membrane fractions from 3T3
cells or astrocytes were incubated with ANTI-FLAG M2-Agarose
aﬃnity gel (Sigma) at 4 C, overnight with gentle rotation. The resin
was sedimented by centrifugation for 30 s at 12000 · g and the super-
natant was removed. The resin was washed three times with 0.5 ml of
wash buﬀer (50 mM Tris–HCl, 15 mM NaCl, pH 7.4).
The immunocomplexes were eluted with 3· FLAG peptide solution
in wash buﬀer. For reciprocal immunoprecipitation, cytosolic and
membrane fractions of NIH 3T3 cells (250 lg of protein) were mixed
with anti-EBP 50 (Chemicon) overnight at 4 C with gentle rotation.
Fifty ll of washed protein A-agarose beads were added to each sample
and incubated for 4 h at 4 C with gentle rotation. Immunocomplexes
with protein A-agarose beads were washed with homogenizing buﬀer
and resuspended in SDS sample buﬀer.
2.9. Electrophoresis and immunoblotting
The immunoprecipitated proteins were resolved on SDS–PAGE
(Invitrogen) and transferred to polyvinylidene ﬂuoride (PVDF) mem-
branes. Membranes were blocked with 5% (w/v) non-fat dry milk
and 0.1% Tween-20 in phosphate buﬀered saline (PBS; 137 mM NaCl,
2.7 mM KCl, 10 mM Na2HPO4, 2 mM KH2PO4, pH 7.4). Membranes
were incubated overnight at 4 C with rabbit anti-EBP50 polyclonal
antibody (Chemicon, Temecula, CA, dilution 1:250), or ANTI-FLAG
M2 monoclonal antibody (Sigma, dilution 1:200). The proteins were
visualized by SuperSignal West Pico Chemiluminescent Substrate,
according to the manufacturer’s (Pierce) instructions.2.10. Statistics
Data are reported as means ± S.E.M for the indicated number of
cells (n). Data were analyzed by ANOVA and Newman–Keuls multiple
comparison test for more than two conditions, or t-test for comparison
between two conditions. Diﬀerences with P < 0.05 were considered sta-
tistically signiﬁcant.3. Results
3.1. Adenylate cyclase and PKA activation inhibit rb2NCBE
activity
To test whether cAMP levels aﬀect NCBE activity, 3T3 cells
stably expressing rb2NCBE were treated with the adenylate
cyclase activator forskolin. Fig. 1A is an example of the
individual traces of rb2NCBE activity in forskolin treated or
non-treated rb2NCBE and control LacZ expressing cells.
Fig. 1B demonstrates that incubating 3T3 cells with 10 lM
of forskolin for 30 min markedly reduced rb2NCBE activity
to 6.2 ± 1.0% compared to untreated rb2NCBE expressing
cells. Untreated LacZ transfected 3T3 cells showed 5.04 ± 0.4
% of recovery rate compared to rb2NCBE expressing cells.
Since forskolin inhibited transport activity, we directly tested
the eﬀect of PKA activation and inhibition on transport activ-
ity. When rb2NCBE expressing cells were incubated with
10 lM of PKA inhibitor fragment 14–22, there was a 1.3-fold
increase in the recovery rate (P < 0.01) and no further increase
was seen at 50 lM (P < 0.001, Fig. 2A and C). Alternatively,
PKA activator 8-Br-cAMP decreased rb2NCBE activity 5.6-
fold at 10 lM (P < 0.001), and 14-fold at 50 lM (P < 0.001)
in rb2NCBE expressing cells (Fig. 2B and D). Thus inhibition
of PKA increased rb2NCBE activity, while activation of PKA
drastically decreased activity.3.2. Disruption of the actin cytoskeleton decreases rb2NCBE
activity
Based on our previous observation that rb2NCBE colocal-
ized with the actin cytoskeleton [6], we tested whether optimal
Fig. 1. Adenylate cyclase activation reduces pHi recovery of cells
expressing rb2NCBE. 3T3 cells stably expressing rb2NCBE and loaded
with BCECF were pretreated for 30 min in the absence or presence of
the adenylate cyclase activator forskolin (10 lM) then pulsed with
40 mM NH4Cl. (A) Individual traces of pHi recovery from forskolin
treated rb2NCBE transfected cells, transfected cells not exposed to
forskolin, and LacZ transfected controls are shown. (B) Relative pHi
recovery rates are shown as a percent of control. The results are
means ± S.E.M of at least 25 cells/condition, pooled from three
diﬀerent experiments. *Signiﬁcant diﬀerence from the control
P < 0.001.
Fig. 2. PKA inhibition accelerates and activation reduces pHi recov-
ery. 3T3 cells stably expressing rb2NCBE were preincubated in the
absence or presence of 10 or 50 lM PKA inhibitor fragments 14–22
(A,C) or cAMP agonist 8 Br-cAMP (B,D) for 30 min. Individual
traces of pHi recovery with time (A, B) and pHi recovery rates as a
percent of control are shown (C,D). The results are means ± S.E.M of
n P 25 cells pooled from three diﬀerent experiments. *Signiﬁcant
diﬀerence from the control rb2NCBE without drug treatment P < 0.01,
**P < 0.001.
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Astrocytes transfected to over-express rb2NCBE were treated
with cytochalasin B to disrupt actin ﬁlaments. As illustrated
in Fig. 3A and B, the well deﬁned actin cytoskeleton in control
astrocytes was much less distinct after a 30-min treatment with
10 lM cytochalasin B. The activity of rb2NCBE was signiﬁ-
cantly reduced when the cytoskeleton was disrupted by cyto-
chalasin B (Fig. 4). The mean dpHi/dt value was
0.044 ± 0.005 pH Units/min in rb2NCBE expressing control
cells and 0.017 ± 0.001 pH Units/min in cytochalasin B treated
cells (P < 0.0001).
3.3. Colocalization of rb2NCBE with EBP50
EBP50 contains two tandem PDZ domains and functions in
a large multiprotein signaling complex, which can include ez-
rin, PKA and NHE3 [9]. Immunoﬂuorescence microscopy
was utilized to determine if rb2NCBE and EBP50 colocalized.
Astrocytes transfected with FLAG-rb2NCBE were immuno-
stained with anti-FLAG antibody and anti-EBP50 antibody
(Fig. 5). rb2NCBE immunoreactivity was observed around cell
membranes with some cytosolic staining and a cytoskeleton-
like staining pattern as previously noted [6]. EBP50 was de-
tected in cytosol but was also prominent in some regions of
the plasma membrane (Fig. 5). The merged image shows colo-
calization in thin processes and patchy colocalization along theplasma membrane (lower row of images, Fig. 5A). Fig. 5B
shows double immunostaining for EBP50 and the actin bind-
ing protein ezrin, with some colocalization seen in the cytosol
at the site of actin ﬁbers, and colocalization around the mem-
branes.
3.4. EBP50 interacts with rb2NCBE
To assess whether EBP50 and rb2NCBE associate in cells,
lysates and membrane fractions of FLAG-rb2NCBE express-
ing astrocytes and 3T3 cells were subjected to immunoprecip-
itation with anti-EBP50 or anti-FLAG antibody, and the
immunoprecipitates were examined for the presence of
FLAG-rb2NCBE and EBP50, respectively (Fig. 6). EBP50
was detected in whole cell lysates from control and FLAG-
rb2NCBE expressing astrocytes (Fig. 6A, lanes 2–3) and 3T3
cells (Fig. 6B, lanes 2–3). Immunoblot analysis showed that
EBP50 was present in the FLAG immunoprecipitates from
Fig. 3. Actin ﬁlaments are disrupted after cytochalasin B treatment. Stably transfected astrocytes were grown on coverslips and were preincubated
without (A) or with (B) 10 lM cytochalasin B for 30 min. Cells were ﬁxed with 4% paraformaldehyde, permeabilized with 0.1% Triton X-100 and
stained with phalloidin-TRITC (Sigma, 1:200). Scale bar = 10 lm.
Fig. 4. Intracellular pH (pHi) recovery in the absence and presence of
cytochalasin B. 3T3 cells stably expressing rb2NCBE were incubated
with (open circle) or without (closed circle) 10 lM cytochalasin B for
10 min. The two traces are superimposed to facilitate comparison.
(n = 18, rb2NCBE control; n = 16, cytochalasin B treated cells). The
results are the means ± S.E.M and diﬀerence in rates of recovery is
P < 0.0001.
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(Fig. 6A, lane 5) and 3T3 cells (Fig. 6B, lane 5). In the converse
experiment, FLAG-rb2NCBE was evident in the EBP50
immunoprecipitate from lysate and membrane fractions of
3T3 cells (Fig. 6C, lanes 2 and 4). We performed parallel
immunoprecipitation experiments using both 3T3 cells and
astrocytes overexpressing rb1NCBE which lacks the PDZ do-
main. We were unable to identify EBP50 in any of the
rb1NCBE immunoprecipitates, consistent with a need for the
PDZ domain for this interaction. These results demonstrate
that rb2NCBE, which contains the PDZ domain, interacts
with EBP50 in both astrocytes and 3T3 cells.4. Discussion
The ion transporters that regulate pH are important to nor-
mal brain function and in the response to pathological insults
such as ischemia. NCBE is expressed in hippocampal neurons
and astrocytes, suggesting an important role in pHi regulation
in the brain [6]. Our previous work described the developmen-
tal expression and functional properties of two splice variants
of the rat brain NCBE. The PDZ motif-containing variant,
rb2NCBE, was much more active in pH regulation, and re-quired Na+, HCO3 and Cl
 for activity [6]. However, how
the transporter’s activity is regulated and whether NCBE
might participate in a complex with other proteins was not
known.
Previous studies of NHE regulation established that EBP50
facilitates the formation of a complex of several proteins,
which includes ezrin and PKA, in addition to NHE3. Phos-
phorylation of NHE3 by PKA was shown to cause down reg-
ulation of its activity [9,19–21]. The organizational state of the
actin cytoskeleton aﬀects NHE3 activity independent of PKA
as inhibition of NHE3 by cytochalasin D was found even with
a mutant of NHE3 that is not phosphorylated by PKA, or
when PKA was inhibited [11]. Our current results with
rb2NCBE begin to paint a similar picture for NCBE. We ﬁnd
evidence for association of rb2NCBE with EBP50, for cAMP
and PKA dependent inhibition of its activity, and reduced
activity when actin is disrupted by cytochalasin B. There is also
evidence for the electrogenic NBC family that PKA phosphor-
ylation regulates the stoichiometry of transport [22] and that
NHERF/EBP50 is also involved in its regulation [14,23]. One
report [24] has examined the eﬀect of 8-Br-cAMP and for-
skolin on NBC3-expressing HEK-293 cells. Treatment with
8-Br-cAMP and forskolin inhibited NBC3-mediated pHi
recovery, with rapid, strong regulation of transporter activity,
similar to our data on NCBE. In human lymphocytes, for-
skolin inhibited the HCO3 mediated pHi recovery, and when
PKA was inhibited by H-89, intracellular alkalization was en-
hanced, suggesting the negative modulation of PKA on HCO3
transport [15].
Although several consensus sites for PKA phosphorylation
are present in the NCBE sequence, it is unknown at this point
which of these sites are phosphorylated in vivo. Furthermore,
it is also possible that some of the eﬀects of cAMP and PKA
observed here are due to phosphorylation of other interacting
proteins in addition to, or even instead of direct phosphoryla-
tion of NCBE. Forskolin has been shown to exert cAMP inde-
pendent eﬀects on some membrane proteins including calcium
and potassium channels [25], so it is also possible that it might
directly aﬀect NCBE. Despite this, the eﬀects of PKA activa-
tion and inhibition observed here were consistent with the ef-
fect of forskolin acting through increased levels of cAMP,
and suggest that NCBE is inhibited by PKA, likely due to di-
rect phosphorylation of the transporter. PKA activation was
associated with reduced pHi recovery while inhibition was
Fig. 5. Colocalization of rb2NCBE with EBP50 and EBP50 with ezrin. (A) Astrocytes stably expressing FLAG-rb2 NCBE were grown on glass
coverslips and were labeled with anti-FLAG (Sigma, 1:500), and detected with Texas Red anti-mouse IgG conjugate (Vector Laboratories, Inc.
1:100). EBP 50 was detected by the rabbit polyclonal anti-EBP50/NHERF antibody (Chemicon, Inc. dilution 1:500) visualized with Fluorescein anti-
rabbit IgG conjugate (Vector Laboratories, Inc. 1:100). Filament-like colocalization patterns seen in the merged images are indicated by arrows. (B)
Astrocytes stably expressing FLAG-rb2 NCBE were double labeled with anti-Ezrin and anti-EPB50 antibodies. EBP50 was detected using the rabbit
polyclonal anti-EBP50/NHERF antibody and visualized with ﬂuorescein anti-rabbit IgG conjugate (Vector Laboratories, Inc. 1:100). Ezrin was
detected with monoclonal anti-ezrin antibody (Sigma, dilution 1:500) and visualized by Texas Red anti-mouse IgG conjugate (Vector Laboratories,
Inc. 1:100). The two rows show two diﬀerent groups of cells. The micrographs are representative of at least three diﬀerent experiments. Scale
bar = 50 lm.
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demonstration of increased cAMP levels and activated PKA,
leading to inhibition of rb2NCBE.
Which protein(s) rb2NCBE interacts with in the cell is not
yet well established. One likely possibility is that the regula-
tory protein, EBP50, which has PDZ domains allowing it
to bind the PDZ motif on the transporter, recruits it to a
complex associated with the plasma membrane and the actincytoskeleton. EBP50 binds to ezrin, a kinase anchoring pro-
tein [26], which binds to the regulatory subunit of type II
PKA [27] and to the actin cytoskeleton [28]. The binding of
ezrin to EBP50 could anchor rb2NCBE to a protein complex
which recruits PKA to the vicinity of the transporter, facili-
tating phosphorylation of NCBE by PKA. A model based
on our observations and the literature is presented in
Fig. 7. EBP50 was shown to bind to ezrin and other ezrin–
Fig. 6. Co-immunoprecipitation of EBP50 with rb2NCBE from
FLAG-rb2NCBE expressing cells. Extracts from membrane fractions
isolated from FLAG-rb2NCBE expressing astrocytes (A) and 3T3 cells
(B) were subjected to immunoprecipitation with antibodies to FLAG.
The immunoprecipitates were analyzed by Western for EBP50 using
anti-NHERF-1/EBP50 antibody (1:250). Signals were visualized by
ECL using horseradish peroxidase-conjugated secondary antibodies.
Lane 1 shows a positive control, EBP50 from human endothelial cells
(8 lg). Lanes 2 and 3 are whole cell lysates from control and FLAG-
rb2NCBE expressing cells (30 lg). Lanes 4 and 5 are the immunopre-
cipitates from control and FLAG-rb2NCBE expressing cells. Similar
results were seen for primary astrocytes (A) and 3T3 cells (B). (C)
EBP50 immunoprecipitates from whole cell lysate (lanes 1–2) and
membrane fraction (lanes 3–4) of control and rb2NCBE transfected
3T3 cells were analyzed by Western for rb2NCBE using anti-FLAG
antibody (1:200). The migration positions of EBP50, FLAG-rb2NCBE
are indicated. Molecular mass is indicated in kDa. Similar results were
obtained in three experiments.
Fig. 7. Hypothetical model of the signal complex involved in the
regulation of Na+-driven Cl=HCO3 exchanger (rb2NCBE).
rb2NCBE, EBP50 and ezrin can exist as a complex at the cell
membrane. The PDZ motif at the COOH-terminus of rb2NCBE can
interact with EBP50. EBP50 interacts with ezrin and ezrin associates
with the actin cytoskeleton via its COOH-terminal actin binding
domain. Protein kinase A (PKA) anchored to ezrin is likely also part of
the complex.
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actin-associated ERM proteins ezrin and radixin were specif-ically localized to ﬁne sheet-like processes or ﬁlopodia of cul-
tured astrocytes [31]. In the present study, we demonstrated
that ezrin occurred around the membranes of the glial pro-
cesses and associated with actin ﬁbers of cultured astrocytes.
Actin ﬁlaments are the primary cytoskeletal compartment in
the peripheral glial processes, preferentially containing ezrin
and radixin, which links the cell membrane to actin ﬁlaments
[28]. ERM proteins can cross link the actin ﬁlaments to the
plasma membrane and stabilize the structure of the leading
edge.
Protein–protein interaction studies showed that NBC3,
which contains the PDZ motif ETSL, binds to the PDZ do-
main of EBP50 [15]. Immunocolocalization further supports
the interaction of rb2NCBE with EBP50 and EBP50 with ez-
rin. The demonstration here that EBP50 could be coimmuno-
precipitated with rb2NCBE suggests this transporter may also
interact with this PDZ domain protein. The mechanism
responsible for inhibition of NCBE activity by cytochalasin
B is unknown at this point, but may reﬂect altered access to
kinases or as was reported for NHE3, may be independent
of PKA.
In summary, inhibition of NCBE transport activity by PKA
activation and forskolin, and co-immunoprecipitation of
EBP50 with rb2NCBE suggest that NCBE may participate
in a large multiprotein complex involving interaction via its
PDZ motif with EBP50 and via additional linking proteins
with actin ﬁlaments. We speculate that interactions of this sort
may allow NCBE to localize to speciﬁc membrane domains
and facilitate the integration of diﬀerent inputs to the regula-
tion of NCBE activity.
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